Recent Company News

• 08:47 AM ET Oct 28, 2025
  

  Merck KGaA partners with Promega to advance 3-D cell drug discovery technologies (€115.55, +1.15)

• 02:18 AM ET Oct 21, 2025
  

  SpringWorks Therapeutics publishes long-term efficacy, safety data from DeFi trial of OGSIVEO in JCO (€112.95, 0.00)

• 10:05 PM ET Oct 17, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 10:03 AM ET Oct 17, 2025
  

  Merck KGaA announces presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib (€110.20, -1.65)

• 08:54 AM ET Oct 17, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:20 AM ET Oct 17, 2025
  

  StreetAccount Themes Headlines (17-Oct)

• 02:01 AM ET Oct 17, 2025
  

  European macro headlines:

• 05:43 PM ET Oct 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 05:04 PM ET Oct 16, 2025
  

  Makary says nine drugs are initial recipients of Commissioner's National PRV

• 04:17 PM ET Oct 16, 2025
  

  Middlemen are joining the MFN movement - Dr Oz